Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Infections 1Hodgkin Disease 1

Interventions

Cyclophosphamide 61fludarabine phosphate 52Peripheral Blood Stem Cell Transplantation 41Busulfan 41Tacrolimus 36Antilymphocyte Serum 34Mycophenolic Acid 33Radiotherapy 30Melphalan 27Filgrastim 27Cyclosporine 25Methotrexate 23Whole-Body Irradiation 21fludarabine 20Methylprednisolone 18Etoposide 17Cord Blood Stem Cell Transplantation 15sargramostim 10Cytarabine 10Rituximab 9Alemtuzumab 9Sirolimus 8Granulocyte Colony-Stimulating Factor 8Epoetin Alfa 7Carmustine 7Stem Cell Transplantation 6Psychiatric Rehabilitation 6Prednisone 6Flow Cytometry 6Trimethoprim, Sulfamethoxazole Drug Combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Nystatin × Other hematologic neoplasm × Clear all
NCT00002742 2013-03-26

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

National Cancer Institute (NCI)

Phase 3 Completed
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡